<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font33 { font-size : 33; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font27 { font-size : 27; } .font28 { font-size : 28; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font33">studies </span>
   <span class="font31">HIV </span>
   <span class="font31">resistance </span>
   <span class="font28">integrase </span>
   <span class="font27">study </span>
   <span class="font26">viral </span>
   <span class="font26">{border-style </span>
   <span class="font25">drug </span>
   <span class="font25">px;} </span>
   <span class="font24">#ffffff;} </span>
   <span class="font23">patients </span>
   <span class="font22">data </span>
   <span class="font22">review </span>
   <span class="font22">systematic </span>
   <span class="font22">treatment </span>
   <span class="font22">use </span>
   <span class="font20">"the </span>
   <span class="font20">HIV- </span>
   <span class="font20">Sub-Saharan </span>
   <span class="font20">[]. </span>
   <span class="font20">bias </span>
   <span class="font19">mutations </span>
   <span class="font18">dolutegravir </span>
   <span class="font18">regimens </span>
   <span class="font17">Health </span>
   <span class="font17">INSTI </span>
   <span class="font17">included </span>
   <span class="font17">level </span>
   <span class="font17">outcomes </span>
   <span class="font17">rate </span>
   <span class="font16">International </span>
   <span class="font16">according </span>
   <span class="font16">help </span>
   <span class="font16">inhibitors </span>
   <span class="font16">px; </span>
   <span class="font16">search </span>
   <span class="font16">{font-family </span>
   <span class="font15">Additional </span>
   <span class="font15">African </span>
   <span class="font15">Available </span>
   <span class="font15">[], </span>
   <span class="font15">antiretroviral </span>
   <span class="font15">assess </span>
   <span class="font15">effect </span>
   <span class="font15">eligible </span>
   <span class="font15">file </span>
   <span class="font15">font-size </span>
   <span class="font15">management </span>
   <span class="font15">regimens. </span>
   <span class="font15">risk </span>
   <span class="font15">studies. </span>
   <span class="font15">subtypes </span>
   <span class="font15">Africa. </span>
   <span class="font15">Conference </span>
   <span class="font15">DTG </span>
   <span class="font15">DTG-based </span>
   <span class="font15">Literature </span>
   <span class="font15">Microsoft </span>
   <span class="font15">[Internet]. </span>
   <span class="font15">alafenamide </span>
   <span class="font15">double; </span>
   <span class="font15">following </span>
   <span class="font15">from: </span>
   <span class="font15">include </span>
   <span class="font15">missing </span>
   <span class="font15">published </span>
   <span class="font15">quality </span>
   <span class="font15">resistance-associated </span>
   <span class="font15">reviews </span>
   <span class="font15">using </span>
   <span class="font14">"drug </span>
   <span class="font14">AIDS </span>
   <span class="font14">Cochrane </span>
   <span class="font14">Commons </span>
   <span class="font14">Creative </span>
   <span class="font14">Data </span>
   <span class="font14">Ngoufack </span>
   <span class="font14">available </span>
   <span class="font14">baseline </span>
   <span class="font14">border-color </span>
   <span class="font14">border-width </span>
   <span class="font14">conducted </span>
   <span class="font14">effects </span>
   <span class="font14">evidence </span>
   <span class="font14">genetic </span>
   <span class="font14">individual </span>
   <span class="font14">inhibitor-based </span>
   <span class="font14">living </span>
   <span class="font14">models </span>
   <span class="font14">randomized </span>
   <span class="font14">results </span>
   <span class="font14">reviewers </span>
   <span class="font14">solid; </span>
   <span class="font14">sources </span>
   <span class="font14">strand </span>
   <span class="font14">suppression </span>
   <span class="font14">tenofovir </span>
   <span class="font14">transfer </span>
   <span class="font14">{font-style </span>
   <span class="font14">{font-weight </span>
   <span class="font13">Africa </span>
   <span class="font13">Excel </span>
   <span class="font13">Ezechiel </span>
   <span class="font13">INSTI-based </span>
   <span class="font13">Jagni </span>
   <span class="font13">Joseph </span>
   <span class="font13">LINK </span>
   <span class="font13">Lancet </span>
   <span class="font13">Mar </span>
   <span class="font13">Medical </span>
   <span class="font13">Ndze, </span>
   <span class="font13">Ngum </span>
   <span class="font13">RAL </span>
   <span class="font13">SSA </span>
   <span class="font13">Semengue, </span>
   <span class="font13">Study </span>
   <span class="font13">Trials </span>
   <span class="font13">University </span>
   <span class="font13">Valantine </span>
   <span class="font13">[cited </span>
   <span class="font13">adherence </span>
   <span class="font13">adults </span>
   <span class="font13">adverse </span>
   <span class="font13">analyses </span>
   <span class="font13">article </span>
   <span class="font13">bold </span>
   <span class="font13">characteristics </span>
   <span class="font13">countries </span>
   <span class="font13">courier; </span>
   <span class="font13">data. </span>
   <span class="font13">duration </span>
   <span class="font13">em; </span>
   <span class="font13">emtricitabine, </span>
   <span class="font13">evidences </span>
   <span class="font13">explore </span>
   <span class="font13">grid.. </span>
   <span class="font13">https://linkinghub.elsevier.com/retrieve/pii/S. </span>
   <span class="font13">immune </span>
   <span class="font13">independently </span>
   <span class="font13">infection </span>
   <span class="font13">initial </span>
   <span class="font13">knowledge </span>
   <span class="font13">meta-analysis </span>
   <span class="font13">multicentre, </span>
   <span class="font13">non-randomized </span>
   <span class="font13">patient </span>
   <span class="font13">people </span>
   <span class="font13">present </span>
   <span class="font13">process </span>
   <span class="font13">protocol </span>
   <span class="font13">pt;} </span>
   <span class="font13">raltegravir </span>
   <span class="font13">refers </span>
   <span class="font13">relevant </span>
   <span class="font13">resolved </span>
   <span class="font13">suppression,ï¿½? </span>
   <span class="font13">tool </span>
   <span class="font13">viruses </span>
  </p>
 </body>
</html>
